Reversal of Memory Deficits by Atorvastatin and Simvastatin in Rats

  • PARLE Milind
    Pharmacology Division, Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology
  • SINGH Nirmal
    Pharmacology Division, Department of Pharmaceutical Sciences and Drug Research, Punjabi University

この論文をさがす

抄録

  The present study was undertaken to investigate the beneficial effects of Atorvastatin and Simvastatin in cognitive dysfunctions of rats. Alprazolam, Scopolamine and high fat diet (HFD) induced amnesia served as interoceptive memory models where as, Water-maze and Elevated plus-maze served as exteroceptive models. A total of 38 groups of rats were used in this investigation. Escape latency time (ELT) recorded during acquisition trials conducted from day 1 to day 4, in water maze was taken as an index of acquisition, where as mean time spent in target quadrant during retrieval trial on day 5, was taken as the index of retrieval (memory). On elevated plus-maze, transfer latency (TL) measured on 1st d served as the index of acquisition and TL recorded on 2nd d was taken as the index of retrieval (memory). Alprazolam (0.5 mg kg-1 intraperitoneally), Scopolamine (0.4 mg kg-1 intraperitoneally) and HFD treated (for 90 days) rats exhibited amnesia as reflected by impairment in learning ability as well as memory, when tested on both, water maze and elevated plus maze. Atorvastatin (5 mg kg-1 orally) as well as Simvastatin (5 mg kg-1 orally) significantly attenuated Alprazolam, Scopolamine and HFD induced amnesia. These results highlight the ameliorative role of statins in experimental amnesia with possible involvement of their cholesterol dependent as well as cholesterol independent actions.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 127 (7), 1125-1137, 2007-07-01

    公益社団法人 日本薬学会

被引用文献 (2)*注記

もっと見る

参考文献 (118)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ